Linear IgA bullous dermatosis associated with immunotherapy

Linear IgA bullous dermatosis (LABD) is a rare mucocutaneus blistering autoimmune disease caused by IgA autoantibodies. Its clinical manifestation can be indistinguishable from bullous pemphigoid (BP), a similar autoimmune bullous disease caused by IgG and IgE autoantibodies. Although BP has been re...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Dermatology online journal 2023-12, Vol.29 (6)
Hauptverfasser: Momin, Bahar, Nguyen, Tue F, Glade, Daniel, Messer, Alison
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 6
container_start_page
container_title Dermatology online journal
container_volume 29
creator Momin, Bahar
Nguyen, Tue F
Glade, Daniel
Messer, Alison
description Linear IgA bullous dermatosis (LABD) is a rare mucocutaneus blistering autoimmune disease caused by IgA autoantibodies. Its clinical manifestation can be indistinguishable from bullous pemphigoid (BP), a similar autoimmune bullous disease caused by IgG and IgE autoantibodies. Although BP has been reported as an adverse cutaneous effect of immunotherapy, LABD has rarely been associated with immunotherapy in the literature. We present the case of a 67-year-old woman with metastatic ovarian cancer receiving anti-PD1 and anti-CTLA4 with new onset pruritic tense bullae to the trunk, hands, elbows (in annular distribution) that occurred after immunotherapy. Skin biopsy showed subepidermal blister with abundant neutrophils on H&E histology, and linear IgA staining at the basement membrane on direct immunofluorescence consistent with the diagnosis of LABD. The condition did not improve on initial prednisone taper, but blisters rapidly resolved a few days after initiation of dapsone therapy. We favor that our patient's LABD is secondary to her immunotherapy. Our case highlights the importance of both H&E histology and direct immunofluorescence in diagnosis of blistering disorders in patients on immunotherapy to help in choosing the most effective treatment option in an attempt to avoid discontinuation of immunotherapy.
doi_str_mv 10.5070/D329662995
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2957164582</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2957164582</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2385-46044ef1bb2e7eada307826e0f4384e3ea57570803e35e5c8b12fde7cfdc5f633</originalsourceid><addsrcrecordid>eNpNkEtLw0AUhQdRbK1u_AGSpQjRm3kHV6W-CgE3ug6TyR07kjR1JkH67420Pjb33MXH4fARcp7BtQAFN3eM5lLSPBcHZJqBVikd7-G_f0JOYnwHoMAFOyYTprnSUsopuS38Gk1Ilm_zpBqaphtiUmNoTd9FHxMTY2e96bFOPn2_SnzbDuuuX2Ewm-0pOXKmiXi2zxl5fbh_WTylxfPjcjEvUkuZFimXwDm6rKooKjS1YaA0lQiOjzuQoRFKKNDAkAkUVlcZdTUq62ornGRsRi53vZvQfQwY-7L10WLTmDWOe0uaC5VJLjQd0asdakMXY0BXboJvTdiWGZTfsso_WSN8se8dqhbrX_THDvsCcENjmw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2957164582</pqid></control><display><type>article</type><title>Linear IgA bullous dermatosis associated with immunotherapy</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Momin, Bahar ; Nguyen, Tue F ; Glade, Daniel ; Messer, Alison</creator><creatorcontrib>Momin, Bahar ; Nguyen, Tue F ; Glade, Daniel ; Messer, Alison</creatorcontrib><description>Linear IgA bullous dermatosis (LABD) is a rare mucocutaneus blistering autoimmune disease caused by IgA autoantibodies. Its clinical manifestation can be indistinguishable from bullous pemphigoid (BP), a similar autoimmune bullous disease caused by IgG and IgE autoantibodies. Although BP has been reported as an adverse cutaneous effect of immunotherapy, LABD has rarely been associated with immunotherapy in the literature. We present the case of a 67-year-old woman with metastatic ovarian cancer receiving anti-PD1 and anti-CTLA4 with new onset pruritic tense bullae to the trunk, hands, elbows (in annular distribution) that occurred after immunotherapy. Skin biopsy showed subepidermal blister with abundant neutrophils on H&amp;E histology, and linear IgA staining at the basement membrane on direct immunofluorescence consistent with the diagnosis of LABD. The condition did not improve on initial prednisone taper, but blisters rapidly resolved a few days after initiation of dapsone therapy. We favor that our patient's LABD is secondary to her immunotherapy. Our case highlights the importance of both H&amp;E histology and direct immunofluorescence in diagnosis of blistering disorders in patients on immunotherapy to help in choosing the most effective treatment option in an attempt to avoid discontinuation of immunotherapy.</description><identifier>ISSN: 1087-2108</identifier><identifier>EISSN: 1087-2108</identifier><identifier>DOI: 10.5070/D329662995</identifier><identifier>PMID: 38478666</identifier><language>eng</language><publisher>United States</publisher><ispartof>Dermatology online journal, 2023-12, Vol.29 (6)</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2385-46044ef1bb2e7eada307826e0f4384e3ea57570803e35e5c8b12fde7cfdc5f633</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,864,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38478666$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Momin, Bahar</creatorcontrib><creatorcontrib>Nguyen, Tue F</creatorcontrib><creatorcontrib>Glade, Daniel</creatorcontrib><creatorcontrib>Messer, Alison</creatorcontrib><title>Linear IgA bullous dermatosis associated with immunotherapy</title><title>Dermatology online journal</title><addtitle>Dermatol Online J</addtitle><description>Linear IgA bullous dermatosis (LABD) is a rare mucocutaneus blistering autoimmune disease caused by IgA autoantibodies. Its clinical manifestation can be indistinguishable from bullous pemphigoid (BP), a similar autoimmune bullous disease caused by IgG and IgE autoantibodies. Although BP has been reported as an adverse cutaneous effect of immunotherapy, LABD has rarely been associated with immunotherapy in the literature. We present the case of a 67-year-old woman with metastatic ovarian cancer receiving anti-PD1 and anti-CTLA4 with new onset pruritic tense bullae to the trunk, hands, elbows (in annular distribution) that occurred after immunotherapy. Skin biopsy showed subepidermal blister with abundant neutrophils on H&amp;E histology, and linear IgA staining at the basement membrane on direct immunofluorescence consistent with the diagnosis of LABD. The condition did not improve on initial prednisone taper, but blisters rapidly resolved a few days after initiation of dapsone therapy. We favor that our patient's LABD is secondary to her immunotherapy. Our case highlights the importance of both H&amp;E histology and direct immunofluorescence in diagnosis of blistering disorders in patients on immunotherapy to help in choosing the most effective treatment option in an attempt to avoid discontinuation of immunotherapy.</description><issn>1087-2108</issn><issn>1087-2108</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNpNkEtLw0AUhQdRbK1u_AGSpQjRm3kHV6W-CgE3ug6TyR07kjR1JkH67420Pjb33MXH4fARcp7BtQAFN3eM5lLSPBcHZJqBVikd7-G_f0JOYnwHoMAFOyYTprnSUsopuS38Gk1Ilm_zpBqaphtiUmNoTd9FHxMTY2e96bFOPn2_SnzbDuuuX2Ewm-0pOXKmiXi2zxl5fbh_WTylxfPjcjEvUkuZFimXwDm6rKooKjS1YaA0lQiOjzuQoRFKKNDAkAkUVlcZdTUq62ornGRsRi53vZvQfQwY-7L10WLTmDWOe0uaC5VJLjQd0asdakMXY0BXboJvTdiWGZTfsso_WSN8se8dqhbrX_THDvsCcENjmw</recordid><startdate>20231215</startdate><enddate>20231215</enddate><creator>Momin, Bahar</creator><creator>Nguyen, Tue F</creator><creator>Glade, Daniel</creator><creator>Messer, Alison</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20231215</creationdate><title>Linear IgA bullous dermatosis associated with immunotherapy</title><author>Momin, Bahar ; Nguyen, Tue F ; Glade, Daniel ; Messer, Alison</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2385-46044ef1bb2e7eada307826e0f4384e3ea57570803e35e5c8b12fde7cfdc5f633</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Momin, Bahar</creatorcontrib><creatorcontrib>Nguyen, Tue F</creatorcontrib><creatorcontrib>Glade, Daniel</creatorcontrib><creatorcontrib>Messer, Alison</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Dermatology online journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Momin, Bahar</au><au>Nguyen, Tue F</au><au>Glade, Daniel</au><au>Messer, Alison</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Linear IgA bullous dermatosis associated with immunotherapy</atitle><jtitle>Dermatology online journal</jtitle><addtitle>Dermatol Online J</addtitle><date>2023-12-15</date><risdate>2023</risdate><volume>29</volume><issue>6</issue><issn>1087-2108</issn><eissn>1087-2108</eissn><abstract>Linear IgA bullous dermatosis (LABD) is a rare mucocutaneus blistering autoimmune disease caused by IgA autoantibodies. Its clinical manifestation can be indistinguishable from bullous pemphigoid (BP), a similar autoimmune bullous disease caused by IgG and IgE autoantibodies. Although BP has been reported as an adverse cutaneous effect of immunotherapy, LABD has rarely been associated with immunotherapy in the literature. We present the case of a 67-year-old woman with metastatic ovarian cancer receiving anti-PD1 and anti-CTLA4 with new onset pruritic tense bullae to the trunk, hands, elbows (in annular distribution) that occurred after immunotherapy. Skin biopsy showed subepidermal blister with abundant neutrophils on H&amp;E histology, and linear IgA staining at the basement membrane on direct immunofluorescence consistent with the diagnosis of LABD. The condition did not improve on initial prednisone taper, but blisters rapidly resolved a few days after initiation of dapsone therapy. We favor that our patient's LABD is secondary to her immunotherapy. Our case highlights the importance of both H&amp;E histology and direct immunofluorescence in diagnosis of blistering disorders in patients on immunotherapy to help in choosing the most effective treatment option in an attempt to avoid discontinuation of immunotherapy.</abstract><cop>United States</cop><pmid>38478666</pmid><doi>10.5070/D329662995</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1087-2108
ispartof Dermatology online journal, 2023-12, Vol.29 (6)
issn 1087-2108
1087-2108
language eng
recordid cdi_proquest_miscellaneous_2957164582
source DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
title Linear IgA bullous dermatosis associated with immunotherapy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T07%3A09%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Linear%20IgA%20bullous%20dermatosis%20associated%20with%20immunotherapy&rft.jtitle=Dermatology%20online%20journal&rft.au=Momin,%20Bahar&rft.date=2023-12-15&rft.volume=29&rft.issue=6&rft.issn=1087-2108&rft.eissn=1087-2108&rft_id=info:doi/10.5070/D329662995&rft_dat=%3Cproquest_cross%3E2957164582%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2957164582&rft_id=info:pmid/38478666&rfr_iscdi=true